Massimo Falconi
Impact in
- Oncology top 0.01%
- Pancreatic and Hepatic Oncology Research
- Lung Cancer Research Studies
- Epidemiology top 0.02%
- Neuroendocrine Tumor Research Advances
Papers in
- Oncology 552
- Pancreatic and Hepatic Oncology Research 469
- Lung Cancer Research Studies 140
- Epidemiology 343
- Neuroendocrine Tumor Research Advances 326
- Co-authors
- Claudio BassiPaolo PederzoliStefano CrippaStefano PartelliRoberto SalviaAldo ScarpaP. PederzoliPaola Capelli
- Journals
- Pancreatology (43 papers)Annals of Surgical Oncology (30 papers)Digestive and Liver Disease (29 papers)Neuroendocrinology (25 papers)Annals of Surgery (24 papers)
- Partner nations
- ItalyUnited StatesCanada
In The Last Decade
Massimo Falconi
640 papers receiving 30.8k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Oncology 26.5k
- Epidemiology 16.1k
- Neurology 6.7k
- Surgery 13.7k
- Gastroenterology 1.1k
Countries citing papers authored by Massimo Falconi
This map shows the geographic impact of Massimo Falconi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Falconi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Falconi more than expected).
Fields of papers citing papers by Massimo Falconi
This network shows the impact of papers produced by Massimo Falconi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Falconi. The network helps show where Massimo Falconi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Massimo Falconi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 14 | |
| 8 | 2024 | 2 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 3 | |
| 12 | 2023 | 5 | |
| 13 | 2023 | 5 | |
| 14 | 2022 | 4 | |
| 15 | 2022 | 10 | |
| 16 | 2022 | 5 | |
| 17 | 2022 | 5 | |
| 18 | 2021 | 8 | |
| 19 | 2016 | 124 | |
| 20 | 2015 | 140 |
About Massimo Falconi
Massimo Falconi is a scholar working on Oncology, Epidemiology, Neurology, Surgery and Cancer Research, having authored 662 papers that have together received 31.4k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (469 papers), Neuroendocrine Tumor Research Advances (326 papers), Pancreatitis Pathology and Treatment (198 papers), Lung Cancer Research Studies (140 papers), Neuroblastoma Research and Treatments (105 papers), Gallbladder and Bile Duct Disorders (63 papers), Cancer Genomics and Diagnostics (62 papers) and Renal cell carcinoma treatment (44 papers). The work is most often cited by research in Oncology (26.5k citations), Epidemiology (16.1k citations), Neurology (6.7k citations), Surgery (13.7k citations) and Gastroenterology (1.1k citations). Massimo Falconi has collaborated with scholars based in Italy, United States and Canada. Frequent co-authors include Claudio Bassi, Paolo Pederzoli, Stefano Crippa, Stefano Partelli, Roberto Salvia, Aldo Scarpa, P. Pederzoli, Paola Capelli, Letizia Boninsegna and Suresh T. Chari. Their work appears in journals such as Pancreatology, Annals of Surgical Oncology, Digestive and Liver Disease, Neuroendocrinology and Annals of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.